{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T02:54:06Z","timestamp":1769741646578,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T00:00:00Z","timestamp":1754179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T00:00:00Z","timestamp":1754179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Health Commission of Sichuan Province Medical Science and Technology Program","award":["24WSXT042"],"award-info":[{"award-number":["24WSXT042"]}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2024-6-113"],"award-info":[{"award-number":["320.6750.2024-6-113"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sichuan Provincial Key Clinical Specialty Development Program","award":["2024HSWKP001"],"award-info":[{"award-number":["2024HSWKP001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-025-04004-x","type":"journal-article","created":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T03:32:26Z","timestamp":1754191946000},"page":"672-681","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum response factor as a prognostic indicator of angiogenesis and early recurrence in Glioblastoma: a retrospective immunohistochemical study"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5976-7546","authenticated-orcid":false,"given":"Bo","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaohui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangyin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,3]]},"reference":[{"issue":"1","key":"4004_CR1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12951-024-02531-3","volume":"22","author":"X Chen","year":"2024","unstructured":"Chen X, Zheng Y, Zhang Q, et al. Dual-targeted delivery of temozolomide by multi-responsive nanoplatform via tumor microenvironment modulation for overcoming drug resistance to treat glioblastoma. J Nanobiotechnol. 2024;22(1):264.","journal-title":"J Nanobiotechnol"},{"issue":"6","key":"4004_CR2","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.ccell.2023.04.010","volume":"41","author":"M Ramachandran","year":"2023","unstructured":"Ramachandran M, Vaccaro A, van de Walle T, et al. Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma. Cancer Cell. 2023;41(6):1134\u201351.","journal-title":"Cancer Cell"},{"issue":"1","key":"4004_CR3","doi-asserted-by":"publisher","first-page":"120784","DOI":"10.1016\/j.biomaterials.2021.120784","volume":"73","author":"J Wang","year":"2021","unstructured":"Wang J, Tang W, Yang M, et al. Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy. Biomat. 2021;73(1):120784\u201397.","journal-title":"Biomat"},{"issue":"2","key":"4004_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/14712598.2022.2157718","volume":"23","author":"ML Varela","year":"2023","unstructured":"Varela ML, Comba A, Faisal SM, et al. Gene therapy for high grade glioma: the clinical experience. Expert Opin Biol Ther. 2023;23(2):145\u201361.","journal-title":"Expert Opin Biol Ther"},{"key":"4004_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.semcancer.2023.03.006","volume":"91","author":"J Luo","year":"2023","unstructured":"Luo J, Pan M, Mo K, et al. Emerging role of artificial intelligence in diagnosis, classification and clinical management of glioma. Semin Cancer Biol. 2023;91:110\u201323.","journal-title":"Semin Cancer Biol"},{"issue":"8","key":"4004_CR6","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1093\/neuonc\/noad033","volume":"25","author":"CG Romo","year":"2023","unstructured":"Romo CG, Piotrowski AF, Campian JL, et al. Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1. Neuro Oncol. 2023;25(8):1474\u201386.","journal-title":"Neuro Oncol"},{"issue":"1","key":"4004_CR7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2463\/mrms.rev.2021-0116","volume":"21","author":"M Matsumae","year":"2022","unstructured":"Matsumae M, Nishiyama J, Kuroda K. Intraoperative MR imaging during glioma resection. Magn Reson Med Sci. 2022;21(1):148\u201367.","journal-title":"Magn Reson Med Sci"},{"issue":"7","key":"4004_CR8","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/jama.2023.0023","volume":"329","author":"LR Schaff","year":"2023","unstructured":"Schaff LR, Mellinghoff IK. Glioblastoma and other primary brain malignancies in adults: a review. JAMA. 2023;329(7):574\u201387.","journal-title":"JAMA"},{"issue":"2","key":"4004_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/14728222.2022.2032652","volume":"26","author":"H Azam","year":"2022","unstructured":"Azam H, Pierro L, Reina M, et al. Emerging role for the serum response factor (SRF) as a potential therapeutic target in cancer. Expert Opin Ther Targets. 2022;26(2):155\u201369.","journal-title":"Expert Opin Ther Targets"},{"issue":"10","key":"4004_CR10","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1111\/febs.15544","volume":"288","author":"JO Onuh","year":"2021","unstructured":"Onuh JO, Qiu H. Serum response factor-cofactor interactions and their implications in disease. FEBS J. 2021;288(10):3120\u201334.","journal-title":"FEBS J"},{"issue":"2","key":"4004_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.30699\/ijp.13.2.205","volume":"13","author":"H Saffar","year":"2018","unstructured":"Saffar H, Mirzaii M, Mirzaian E, et al. Assessment of micro-vessel density in brain glioma by CD105 expression. Iran J Pathol. 2018;13(2):205\u201311.","journal-title":"Iran J Pathol"},{"issue":"11\u201312 Pt 2","key":"4004_CR12","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1016\/j.lpm.2018.04.015","volume":"47","author":"C Villa","year":"2018","unstructured":"Villa C, Miquel C, Mosses D, et al. The 2016 World Health Organization classification of tumours of the central nervous system. Presse Med. 2018;47(11\u201312 Pt 2):e187\u2013200.","journal-title":"Presse Med"},{"issue":"3","key":"4004_CR13","first-page":"217","volume":"35","author":"National Health Commission of the People\u2019s Republic of China","year":"2019","unstructured":"National Health Commission of the People\u2019s Republic of China. Diagnostic and therapeutic guidelines for glioma (2018 edition). Chin J Neurol Surg. 2019;35(3):217\u201339.","journal-title":"Chin J Neurol Surg"},{"issue":"10","key":"4004_CR14","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/pros.23516","volume":"78","author":"M Prencipe","year":"2018","unstructured":"Prencipe M, Fabre A, Murphy TB, et al. Role of serum response factor expression in prostate cancer biochemical recurrence. Prostate. 2018;78(10):724\u201330.","journal-title":"Prostate"},{"issue":"2","key":"4004_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10456-012-9328-3","volume":"16","author":"A Eichten","year":"2013","unstructured":"Eichten A, Adler AP, Cooper B, et al. Rapid decrease in tumor perfusion following VEGF blockade predicts long-term tumor growth inhibition in preclinical tumor models. Angiogenesis. 2013;16(2):429\u201341.","journal-title":"Angiogenesis"},{"key":"4004_CR16","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jconrel.2022.09.065","volume":"352","author":"T Li","year":"2022","unstructured":"Li T, Li J, Chen Z, et al. Glioma diagnosis and therapy: current challenges and nanomaterial-based solutions. J Control Release. 2022;352:338\u201370.","journal-title":"J Control Release"},{"issue":"1","key":"4004_CR17","first-page":"vdad091","volume":"5","author":"N Samuel","year":"2023","unstructured":"Samuel N, Harmsen IE, Ding MYR, et al. Investigation of neurophysiologic and functional connectivity changes following glioma resection using magnetoencephalography. Neurooncol Adv. 2023;5(1):vdad091.","journal-title":"Neurooncol Adv"},{"issue":"2","key":"4004_CR18","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/neuonc\/noab199","volume":"24","author":"GM Wang","year":"2022","unstructured":"Wang GM, Cioffi G, Patil N, et al. Importance of the intersection of age and sex to understand variation in incidence and survival for primary malignant gliomas. Neuro Oncol. 2022;24(2):302\u201310.","journal-title":"Neuro Oncol"},{"key":"4004_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1420182","volume":"15","author":"S Zhang","year":"2024","unstructured":"Zhang S, Cheng L, Su Y, et al. AGBL4 promotes malignant progression of glioblastoma via modulation of MMP-1 and inflammatory pathways. Front Immunol. 2024;15: 1420182.","journal-title":"Front Immunol"},{"issue":"14","key":"4004_CR20","doi-asserted-by":"publisher","first-page":"13885","DOI":"10.1021\/acsnano.3c03696","volume":"17","author":"D Nie","year":"2023","unstructured":"Nie D, Ling Y, Lv W, et al. In situ attached photothermal immunomodulation-enhanced nanozyme for the inhibition of postoperative malignant glioma recurrence. ACS Nano. 2023;17(14):13885\u2013902.","journal-title":"ACS Nano"},{"issue":"6","key":"4004_CR21","first-page":"668","volume":"27","author":"CF Chen","year":"2024","unstructured":"Chen CF, Chen B, Yang SJ, et al. MRI-based perfusion imaging histogram features for predicting recurrence of high-grade gliomas. Chin J Pract Neurol Dis. 2024;27(6):668\u201373.","journal-title":"Chin J Pract Neurol Dis"},{"issue":"2","key":"4004_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/genes13020244","volume":"13","author":"BP Setlai","year":"2022","unstructured":"Setlai BP, Hull R, Reis RM, et al. Microrna interrelated epithelial-mesenchymal transition (EMT) in glioblastoma. Genes. 2022;13(2): 244.","journal-title":"Genes"},{"issue":"1","key":"4004_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41419-022-04518-0","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, Zhong Q, Zhang H, et al. Nogo-B promotes invasion and metastasis of nasopharyngeal carcinoma via RhoA-SRF-MRTFA pathway. Cell Death Dis. 2022;13(1):76.","journal-title":"Cell Death Dis"},{"issue":"5","key":"4004_CR24","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.210383","volume":"12","author":"O Kuchler","year":"2022","unstructured":"Kuchler O, Gerlach J, Vomhof T, et al. Single-molecule tracking (SMT) and localization of SRF and MRTF transcription factors during neuronal stimulation and differentiation. Open Biol. 2022;12(5): 210383.","journal-title":"Open Biol"},{"key":"4004_CR25","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.75106","volume":"11","author":"CJ Dinsmore","year":"2022","unstructured":"Dinsmore CJ, Soriano P. Differential regulation of cranial and cardiac neural crest by serum response factor and its cofactors. Elife. 2022;11: e75106.","journal-title":"Elife"},{"issue":"4","key":"4004_CR26","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.3390\/cancers15041319","volume":"15","author":"M Xu","year":"2023","unstructured":"Xu M, Zhu F, Yin Q, et al. Serum response factor-regulated IDO1\/Kyn-Ahr pathway promotes tumorigenesis of oral squamous cell carcinoma. Cancers (Basel). 2023;15(4):1319.","journal-title":"Cancers (Basel)"},{"key":"4004_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.humpath.2018.10.018","volume":"85","author":"J Yin","year":"2019","unstructured":"Yin J, Lv X, Hu S, et al. Overexpression of serum response factor is correlated with poor prognosis in patients with gastric cancer. Hum Pathol. 2019;85:10\u20137.","journal-title":"Hum Pathol"},{"key":"4004_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijporl.2023.111746","volume":"174","author":"R Jaiswal","year":"2023","unstructured":"Jaiswal R, Goel MM, Mishra A. Microvessel density (cluster of differentiation-34 & vascular endothelial growth factor) in nasopharyngeal angiofibroma: clinical correlation. Int J Pediatr Otorhinolaryngol. 2023;174: 111746.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"4","key":"4004_CR29","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1161\/CIRCRESAHA.122.321109","volume":"131","author":"MM Orlich","year":"2022","unstructured":"Orlich MM, Di\u00e9guez-Hurtado R, Muehlfriedel R, et al. Mural cell SRF controls pericyte migration, vessel patterning, and blood flow. Circ Res. 2022;131(4):308\u201327.","journal-title":"Circ Res"},{"issue":"1","key":"4004_CR30","doi-asserted-by":"publisher","first-page":"e15734056287859","DOI":"10.2174\/0115734056287859240319062720","volume":"20","author":"T Song","year":"2024","unstructured":"Song T, Wang D, Zhang Y, et al. Effects of glutamine synthetase on neovascularization in glioma: in vivo MR vessel size imaging and histology. Curr Med Imaging. 2024;20(1):e15734056287859.","journal-title":"Curr Med Imaging"},{"key":"4004_CR31","volume":"27","author":"D Liu","year":"2023","unstructured":"Liu D, Liu W. Diagnostic effect of MRI diffusion-weighted imaging apparent diffusion coefficient value on postoperative recurrence of brain glioma. Altern Ther Health Med. 2023;27: AT9342.","journal-title":"Altern Ther Health Med"},{"issue":"11","key":"4004_CR32","first-page":"1321","volume":"26","author":"Ma Qiang","year":"2023","unstructured":"Qiang Ma, Zhen Y, Hao C, et al. Correlation between serum miR-27b-3p levels and postoperative recurrence in brain glioma patients. Chin J Pract Neurol Dis. 2023;26(11):1321\u20135.","journal-title":"Chin J Pract Neurol Dis"},{"key":"4004_CR33","doi-asserted-by":"publisher","first-page":"899710","DOI":"10.3389\/fimmu.2022.899710","volume":"13","author":"C Eng","year":"2022","unstructured":"Eng C, Zhu Y, Li Y, et al. Recurrence-and malignant progression-associated biomarkers in low-grade gliomas and their roles in immunotherapy. Front Immunol. 2022;13:899710.","journal-title":"Front Immunol"},{"issue":"1","key":"4004_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-11996-2","volume":"24","author":"W Qiao","year":"2024","unstructured":"Qiao W, Wang Y, Luo C, et al. Development of preoperative and postoperative models to predict recurrence in postoperative glioma patients: a longitudinal cohort study. BMC Cancer. 2024;24(1): 274.","journal-title":"BMC Cancer"},{"issue":"7","key":"4004_CR35","first-page":"1092","volume":"18","author":"H Haixia","year":"2014","unstructured":"Haixia H, Yubao D, Xiaohua W, et al. Expression of Snail and SRF in human malignant glioma and their relationship with microvessel density. Chin J Lab Diagn. 2014;18(7):1092\u20133.","journal-title":"Chin J Lab Diagn"},{"key":"4004_CR36","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/cai2.59","volume":"2","author":"W Zhang","year":"2023","unstructured":"Zhang W, Wang Z, Luo Y, et al. Progress in phase III clinical trials of molecular targeted therapy and immunotherapy for glioblastoma. Cancer Innov. 2023;2:114\u201330.","journal-title":"Cancer Innov"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04004-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-025-04004-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04004-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T13:46:59Z","timestamp":1769694419000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-025-04004-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,3]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["4004"],"URL":"https:\/\/doi.org\/10.1007\/s12094-025-04004-x","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,3]]},"assertion":[{"value":"24 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the ethics committee of Guangyuan Central Hospital. Written informed consent was obtained from all participants before their involvement in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors have read and approved the final manuscript, and consent to the publication of the data in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}